Marsico Capital Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-97,272
Closed -$29.3M 87
2018
Q4
$29.3M Sell
97,272
-8,553
-8% -$2.73M 1.24% 23
2018
Q3
$37.4M Buy
+105,825
New +$36.4M 1.26% 21
2015
Q3
Sell
-1,282,348
Closed -$518M 95
2015
Q2
$518M Sell
1,282,348
-536,523
-29% -$215M 4.58% 4
2015
Q1
$768M Buy
1,818,871
+211,715
+13% +$83.4M 6.48% 2
2014
Q4
$546M Sell
1,607,156
-127,210
-7% -$41.2M 4.38% 5
2014
Q3
$574M Sell
1,734,366
-192,700
-10% -$63.5M 4.49% 3
2014
Q2
$608M Sell
1,927,066
-558,593
-22% -$168M 4.41% 6
2014
Q1
$760M Sell
2,485,659
-35,572
-1% -$11.3M 5.48% 3
2013
Q4
$705M Sell
2,521,231
-355,788
-12% -$92M 4.99% 4
2013
Q3
$693M Sell
2,877,019
-1,120,735
-28% -$251M 5.12% 2
2013
Q2
$860M Buy
+3,997,754
New +$854M 5.4% 2

Other funds holding BIIB

Marsico Capital Management's BIIB Position: Q1 2019 in Review

Marsico Capital Management sold out of Biogen (BIIB) in Q1 2019, closing a stake of 97,272 shares — an estimated $29.3M sold.

Marsico Capital Management first reported a position in BIIB in Q2 2013 and held it in 11 quarters. The position peaked at $860M in Q2 2013. 1,084 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.

  • Marsico Capital Management reported no remaining Biogen position as of Q1 2019 after selling out during the quarter.
  • Marsico Capital Management sold 97,272 Biogen shares in Q1 2019, an estimated $29.3M.
  • Marsico Capital Management first reported a position in Biogen in Q2 2013 and held it in 11 quarters.
  • Marsico Capital Management's Biogen position peaked at $860M in Q2 2013.
  • 1,084 funds tracked by Wall St. Rank held Biogen as of Q1 2019.

Based on Marsico Capital Management's 13F filing for Q1 2019, filed 15 May 2019.